October 2023

As with all patients with cancer, providing care for those with lung cancer involves both physiological and psychological aspects.

A lung cancer screening navigator offers their perspective on shared decision-making.

Capmatinib and tepotinib are highly selective kinase inhibitors targeting MET.

Thyroid carcinoma is recognized as one of the most uncommon forms of cancer.

Chemotherapy shortages are affecting patients across the country.

Linda Bloom, MPA, RN, OCN, explains how amplifiers and audio interpreter tablets can be vital resources during cancer care.

The FDA has granted accelerated approval to elranatamab-bcmm to treat adults with relapsed or refractory multiple myeloma who have already undergone 4 prior lines of treatment.

The FDA has approved niraparib and abiraterone acetate to treat patients with deleterious or suspected deleterious BRCA-positive mCRPC, as detected by an FDA-approved test.